Find information on thousands of medical conditions and prescription drugs.

Etodolac

Etodolac is the International Nonproprietary Name(INN) of 1,8-diethyl-1,3,4,9-tetrahydropyrano-indole-1-acetic acid (empirical formula C17H21NO3), sold under the trade name Lodine. It is a non-steroidal anti-inflammatory drug(NSAID). It is used to treat pain associated with arthritis and other conditions.

Home
Diseases
Medicines
A
B
C
D
E
E-Base
Ecstasy (drug)
Edecrin
Edrophonium
Edrophonium chloride
Efavirenz
Effexor
Eflornithine
Elavil
Eldepryl
Elidel
Eligard
Elitek
Elixomin
Elixophyllin
Ellagic acid
Elmiron
Eloxatin
Elspar
Emtriva
Emylcamate
Enalapril
Enalaprilat
Enalaprilat
Endep
Enflurane
Enoxaparin sodium
Entacapone
Enulose
Epi-pen
Epinephrine
Epirubicin
Epitol
Epivir
Epogen
Eprosartan
Ergocalciferol
Ergoloid Mesylates
Ergotamine
Eryc
Eryped
Erythromycin
Esgic
Eskalith
Esmolol
Estazolam
Estazolam
Estrace
Estraderm
Estradiol
Estradiol
Estradiol valerate
Estring
Estrogel
Estrone
Estrostep
Ethacridine
Ethambutol
Ethchlorvynol
Ethosuximide
Ethotoin
Etiracetam
Etodolac
Etopophos
Etoposide
Etorphine
Evista
Exelon
Exemestane
Hexal Australia
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Purepac gains permission to add to etodolac line
From Drug Store News, 6/22/98

International pharmaceutical and healthcare company F. H. Faulding & Co. Ltd. recently announced that its wholly owned subsidiary, Purepac Pharmaceutical Co., has received clearance from the Food and Drug Administration to manufacture and market etodolac 500mg

Richard F. Moldin, chief executive officer of Faulding Oral pharmaceuticals, said, "Our 500 mg etodolac tablets are the generic equivalent of Wyeth-Ayerst Laboratories Lodine(r) brand 500 mg tablets, indicated for acute and long-term use in the management of osteoarthritis and pain. It is an extension of our existing etodolac product line, which already includes etodolac 400 mg tablets, which have been marketed since March 1997." Brand sales for etodolac 500 mg tablets are estimated to be in excess of $45 million for the past 12 months. Purepac will commence commercial immediately.

Faulding Oral Pharmaceuticals develops, manufactures and markets human pharmaceuticals medical devices.

For more information, call (908) 527-9100.

COPYRIGHT 1998 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2004 Gale Group

Return to Etodolac
Home Contact Resources Exchange Links ebay